Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

Feb 1, 2007

29777_dirs_2007-01-31_c0b362cf-c4d0-4646-a841-6d2bb4683987.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-01-29

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-01-29 Common shares without par value S 1845 $52.57 Disposed 219698 Direct
2007-01-29 Common shares without par value M 31131 $41.6426 Acquired 250829 Direct
2007-01-29 Common shares without par value M 24684 $41.0693 Acquired 275513 Direct
2007-01-29 Common shares without par value M 39015 $41.0317 Acquired 314528 Direct
2007-01-29 Common shares without par value F 80634 $52.55 Disposed 233894 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-01-29 Option (right to buy) $41.6426 M 31131 Disposed 2013-02-13 Common shares (31131) Direct
2007-01-29 Option (right to buy) $41.0693 M 24684 Disposed 2010-02-10 Common shares (24684) Direct
2007-01-29 Option (right to buy) $41.0317 M 39015 Disposed 2014-02-19 Common Shares (39015) Direct
2007-01-29 Option (right to buy) $52.55 A 26572 Acquired 2013-02-13 Common shares (26572) Direct
2007-01-29 Option (right to buy) $52.55 A 20882 Acquired 2010-02-10 Common shares (20882) Direct
2007-01-29 Option (right to buy) $52.55 A 33180 Acquired 2014-02-19 Common Shares (33180) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 18956 Indirect
Common shares without par value 466 Indirect
Common shares without par value 466 Indirect
Common shares without par value 466 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2007.

F2: Reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.